dc.creatorCamara, María de los Milagros
dc.creatorBouvier, León Alberto
dc.creatorReigada, Chantal
dc.creatorDi Girolamo, Fabio Augusto
dc.creatorMartínez Sayé, Melisa Soledad
dc.creatorPereira, Claudio Alejandro
dc.date.accessioned2018-06-04T20:32:18Z
dc.date.accessioned2018-11-06T15:50:10Z
dc.date.available2018-06-04T20:32:18Z
dc.date.available2018-11-06T15:50:10Z
dc.date.created2018-06-04T20:32:18Z
dc.date.issued2017-02
dc.identifierCamara, María de los Milagros; Bouvier, León Alberto; Reigada, Chantal; Di Girolamo, Fabio Augusto; Martínez Sayé, Melisa Soledad; et al.; A novel stage-specific glycosomal nucleoside diphosphate kinase from Trypanosoma cruzi; Czech Academy of Sciences. Institute of Parasitology; Folia Parasitologica; 64; 2-2017; 1-6
dc.identifier0015-5683
dc.identifierhttp://hdl.handle.net/11336/47227
dc.identifier1803-6465
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1901678
dc.description.abstractNucleoside diphosphate kinases (NDPK) are key enzymes involved in the intracellular nucleotide maintenance in all living organisms, especially in trypanosomatids which are unable to synthesise purines de novo. Four putative NDPK isoforms were identified in the Trypanosoma cruzi Chagas, 1909 genome but only two of them were characterised so far. In this work, we studied a novel isoform from T. cruzi called TcNDPK3. This enzyme presents an atypical N-terminal extension similar to the DM10 domains. In T. cruzi, DM10 sequences targeted other NDPK isoform (TcNDPK2) to the cytoskeleton, but TcNDPK3 was localised in glycosomes despite lacking a typical peroxisomal targeting signal. In addition, TcNDPK3 was found only in the bloodstream trypomastigotes where glycolytic enzymes are very abundant. However, TcNDPK3 mRNA was also detected at lower levels in amastigotes suggesting regulation at protein and mRNA level. Finally, 33 TcNDPK3 gene orthologs were identified in the available kinetoplastid genomes. The characterisation of new glycosomal enzymes provides novel targets for drug development to use in therapies of trypanosomatid associated diseases.
dc.languageeng
dc.publisherCzech Academy of Sciences. Institute of Parasitology
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://folia.paru.cas.cz/artkey/fol-201701-0006_a_novel_stage-specific_glycosomal_nucleoside_diphosphate_kinase_from_trypanosoma_cruzi.php
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.14411/fp.2017.006
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectENERGY METABOLISM
dc.subjectTRYPANOSOMATIDS
dc.subjectCHAGAS DISEASE
dc.subjectGLYCOSOMES
dc.subjectTRYPOMASTIGOTES
dc.titleA novel stage-specific glycosomal nucleoside diphosphate kinase from Trypanosoma cruzi
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución